company background image
300841 logo

Chengdu Kanghua Biological Products SZSE:300841 Stock Report

Last Price

CN¥55.92

Market Cap

CN¥7.3b

7D

1.6%

1Y

-18.3%

Updated

14 Jun, 2024

Data

Company Financials +

Chengdu Kanghua Biological Products Co., Ltd.

SZSE:300841 Stock Report

Market Cap: CN¥7.3b

Chengdu Kanghua Biological Products Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chengdu Kanghua Biological Products
Historical stock prices
Current Share PriceCN¥55.92
52 Week HighCN¥84.05
52 Week LowCN¥44.78
Beta2.49
1 Month Change-9.37%
3 Month Change-16.11%
1 Year Change-18.27%
3 Year Change-69.46%
5 Year Changen/a
Change since IPO24.17%

Recent News & Updates

Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Feb 27
Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Recent updates

Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Feb 27
Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Shareholder Returns

300841CN BiotechsCN Market
7D1.6%1.4%-0.07%
1Y-18.3%-18.7%-15.5%

Return vs Industry: 300841 matched the CN Biotechs industry which returned -18.7% over the past year.

Return vs Market: 300841 underperformed the CN Market which returned -15.5% over the past year.

Price Volatility

Is 300841's price volatile compared to industry and market?
300841 volatility
300841 Average Weekly Movement6.5%
Biotechs Industry Average Movement6.3%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 300841 has not had significant price volatility in the past 3 months.

Volatility Over Time: 300841's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004672n/awww.kangh.com

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines.

Chengdu Kanghua Biological Products Co., Ltd. Fundamentals Summary

How do Chengdu Kanghua Biological Products's earnings and revenue compare to its market cap?
300841 fundamental statistics
Market capCN¥7.35b
Earnings (TTM)CN¥553.49m
Revenue (TTM)CN¥1.61b

13.4x

P/E Ratio

4.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300841 income statement (TTM)
RevenueCN¥1.61b
Cost of RevenueCN¥98.75m
Gross ProfitCN¥1.51b
Other ExpensesCN¥958.40m
EarningsCN¥553.49m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.17
Gross Margin93.87%
Net Profit Margin34.36%
Debt/Equity Ratio5.8%

How did 300841 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

48%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.